Back

Exploring the impact of age and comorbidities on quality-of-life improvements with empagliflozin: findings from a broad European real-world population

31 August 2026 (13:15 - 13:27)
Organised by: Logo
Congress Presentation Part of: A deep dive into mechanisms underlying heart failure Cardiotoxicity of Drugs and Other Therapies ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speakers

Photo
Professor Anna Tomaszuk-Kazberuk

Medical University of Bialystok, Bialystok (Poland)

Photo
Professor Filip Malek

Na Homolce Hospital, Prague (Czechia)

4 More presentations in this session

Presentation thumbnail
Klotho regulates myocardial function in living human slices and cardiorenal phenotype in Klotho-deficient swine model
Ms I. Ornek (Munich, DE)
Abstract Slides Video
Presentation thumbnail
Z-disc mechanosensory integrity dictates cardiac reverse remodeling: insights from multiscale imaging and gene-edited rat models
Mr H. Wang (Beijing, CN)
Abstract Slides Video
Presentation thumbnail
Non-canonical VEGFA N-terminal peptide functions as a nuclear regulator driving age-dependent cardiac remodelling
Doctor Z. Chen (Shanghai, CN)
Abstract Slides Video
Presentation thumbnail
Mitochondrial DNA integrity and antioxidant determinants of resilience to anthracycline-induced cardiotoxicity
Mr I. Dias (Groningen, NL)
Abstract Slides Video

Access the full session

Session thumbnail
A deep dive into mechanisms underlying heart failure
Video

The Event

Event poster

ESC Congress 2026

31 August 2026 13:15 CET
You may be interested in
thumbnail
Congress Presentation
Quality of life of heart failure patients treated with sacubitril/valsartan in a real-world setting: evidence from Portugal
29 June 2021
thumbnail
Congress Presentation
Empagliflozin use versus dipeptidyl peptidase 4 inhibitors reduces risk of cardiovascular and renal disease among type 2 diabetes patients in routine care in europe and israel: EMPRISE study results
29 June 2021
thumbnail
Congress Presentation
Real-world treatments and outcomes in very old patients with heart failure with preserved ejection fraction
12 May 2026
thumbnail
Congress Presentation
Multiparametric evaluation of the effects of dapagliflozin in patients with heart failure and reduced ejection fraction
21 May 2023

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources